Nutritionals

Probi 2012 sales up 6%, but ProViva royalties set for dive

Probi 2012 sales up 6%, but ProViva royalties set for dive

By Shane Starling

The European probiotic sector is bracing itself for tough times ahead in the wake of December’s  EU health claim ban for the sector, but the effects are yet to be felt at Swedish supplier Probi which notched 6% sales growth in 2012.

Chr Hansen backs fresh probiotic immunity trial

Chr Hansen backs fresh probiotic immunity trial

Danish probiotics leader Chr Hansen, which ditched a €4m immunity trial for some of its probiotic strains last year, is participating in a new trial to determine if probiotics can reduce the number of infections in small children.

Follow us

Featured Events

View more

Products

View more

Webinars